Wonbiogen Co (XKRX:307280) EPS (Basic): ₩999.00 (TTM As of Mar. 2026)


XKRX:307280 Wonbiogen Co Ltd XKRX:307280
89 GF Score
Price ₩5,380.00
GF Value ₩5,070.64
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Wonbiogen Co EPS (Basic)?

Wonbiogen Co XKRX:307280 -2.00% 89 EPS (Basic) is ₩999.00 as of Mar. 2026. GuruFocus rates XKRX:307280 with a GF Score™ of 89/100 and a GF Value™ of ₩5,070.64 (Fairly Valued). The stock has 1 warning sign investors should review.

Wonbiogen Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₩241.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₩999.00.

Wonbiogen Co's EPS (Diluted) for the three months ended in Mar. 2026 was ₩241.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₩999.00.

Wonbiogen Co's EPS without NRI for the three months ended in Mar. 2026 was ₩245.45. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 1,073.55.

During the past 12 months, Wonbiogen Co's average EPS without NRIGrowth Rate was -75.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 27.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Wonbiogen Co's highest 3-Year average EPS without NRI Growth Rate was 114.10% per year. The lowest was -47.80% per year. And the median was 27.10% per year.

Wonbiogen Co  (XKRX:307280) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Wonbiogen Co EPS (Basic) Related Terms

Wonbiogen Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Wonbiogen Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wonbiogen Co EPS (Basic) Chart

Wonbiogen Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial -105.00 450.00 785.00 4,010.00 933.00

Wonbiogen Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 875.00 226.00 307.00 225.00 241.00
XKRX:307280
89GF Score
Wonbiogen Co Ltd XKRX:307280
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wonbiogen Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Wonbiogen Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(6615.249-0)/7.090
=933.04

Wonbiogen Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1669.924-0)/6.927
=241.07

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩999.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₩999.00 mean?
Wonbiogen Co (XKRX:307280) has a EPS (Basic) of ₩999.00 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Wonbiogen Co and its competitors.
Is Wonbiogen Co's EPS (Basic) too high?
Wonbiogen Co's current EPS (Basic) is ₩999.00. Overall, Wonbiogen Co has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wonbiogen Co's EPS (Basic) compare to ISRG and BDX?
Wonbiogen Co's EPS (Basic) of ₩999.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Wonbiogen Co and its competitors. Wonbiogen Co's current EPS (Basic) is ₩999.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wonbiogen Co stock overvalued right now?
Based on GuruFocus' analysis, Wonbiogen Co (XKRX:307280) is currently considered Fairly Valued. The stock's GF Value™ is ₩5,070.64, compared to a current price of ₩5,380.00 — trading 6.1% above its estimated fair value. The current EPS (Basic) is ₩999.00. Wonbiogen Co's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Wonbiogen Co (XKRX:307280), the current EPS (Basic) is ₩999.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wonbiogen Co (XKRX:307280) Overvalued in 2026?

Based on GuruFocus' analysis, Wonbiogen Co stock appears to be overvalued. The current stock price of ₩5,380.00 is trading 6.1% above its estimated GF Value™ of ₩5,070.64. GuruFocus considers Wonbiogen Co to be Fairly Valued.

Key valuation signals for XKRX:307280:

  • EPS (Basic): ₩999.00
  • GF Value™: ₩5,070.64 vs. price of ₩5,380.00 (6.1% above fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the XKRX:307280 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wonbiogen Co Business Description

Address 56, 1st Industrial Complex Road 5-gil, Gyeongsangbuk-do, Gumi-si, KOR
Wonbiogen Co Ltd is engaged in the manufacturing of medical supplies and instruments. Its product portfolio comprises Therasorb Algi Adhesive, Therasorb AD, Renoderm, Remscar Gel, Meditouch Liquid, and Meditouch Bend, among others.
89GF Score

Get the complete analysis for XKRX:307280

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩5,380.00
Price
₩5,070.64
GF Value